The success of RNA-based therapies and vaccines depends on more than the choice of active ingredients. Researchers must also develop reliable formulation processes that produce consistent nanoparticles and support further process development. Lipid nanoparticles (LNPs) have become an important area of research because they can deliver nucleic acids such as messenger RNA (mRNA) and small...